Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43


Race and gender differences in 1-year outcomes for community-dwelling stroke survivors with family caregivers.

Roth DL, Haley WE, Clay OJ, Perkins M, Grant JS, Rhodes JD, Wadley VG, Kissela B, Howard G.

Stroke. 2011 Mar;42(3):626-31. doi: 10.1161/STROKEAHA.110.595322. Epub 2011 Jan 21.


Three-month stroke outcome: the European Registers of Stroke (EROS) investigators.

Heuschmann PU, Wiedmann S, Wellwood I, Rudd A, Di Carlo A, Bejot Y, Ryglewicz D, Rastenyte D, Wolfe CD; European Registers of Stroke.

Neurology. 2011 Jan 11;76(2):159-65. doi: 10.1212/WNL.0b013e318206ca1e. Epub 2010 Dec 9.


Auckland Stroke Outcomes Study. Part 1: Gender, stroke types, ethnicity, and functional outcomes 5 years poststroke.

Feigin VL, Barker-Collo S, Parag V, Senior H, Lawes CM, Ratnasabapathy Y, Glen E; ASTRO study group.

Neurology. 2010 Nov 2;75(18):1597-607. doi: 10.1212/WNL.0b013e3181fb44b3.


N-terminal probrain natriuretic peptide predicts 1-year mortality following acute stroke: possible evidence of occult cardiac dysfunction among patients with acute stroke.

Idris I, Hill R, Ross I, Sharma JC.

Age Ageing. 2010 Nov;39(6):752-5. doi: 10.1093/ageing/afq098. Epub 2010 Sep 16. No abstract available.


Gender differences in outcomes after ischemic stroke: role of ischemic lesion volume and intracranial large-artery occlusion.

Silva GS, Lima FO, Camargo EC, Smith WS, Lev MH, Harris GJ, Halpern EF, Koroshetz W, Furie KL.

Cerebrovasc Dis. 2010;30(5):470-5. doi: 10.1159/000317088. Epub 2010 Aug 24.


Time to treatment and acute coronary syndromes: bridging the gap in rapid decision making.

Peacock WF.

Rev Cardiovasc Med. 2010;11 Suppl 2:S45-50. Review.


Factors affecting the B-type natriuretic peptide levels in stroke patients.

Saritas A, Cakir Z, Emet M, Uzkeser M, Akoz A, Acemoglu H.

Ann Acad Med Singapore. 2010 May;39(5):385-9.


Plasma brain natriuretic peptide predicts death during hospitalization in acute ischaemic stroke and transient ischaemic attack patients with atrial fibrillation.

Shibazaki K, Kimura K, Iguchi Y, Aoki J, Sakai K, Kobayashi K.

Eur J Neurol. 2011 Jan;18(1):165-9. doi: 10.1111/j.1468-1331.2010.03101.x.


Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke.

Jimenez-Conde J, Biffi A, Rahman R, Kanakis A, Butler C, Sonni S, Massasa E, Cloonan L, Gilson A, Capozzo K, Cortellini L, Ois A, Cuadrado-Godia E, Rodriguez-Campello A, Furie KL, Roquer J, Rosand J, Rost NS.

Stroke. 2010 Mar;41(3):437-42. doi: 10.1161/STROKEAHA.109.563502. Epub 2010 Feb 4. Erratum in: Stroke. 2017 Aug;48(8):e241.


Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.

Schnabel RB, Larson MG, Yamamoto JF, Sullivan LM, Pencina MJ, Meigs JB, Tofler GH, Selhub J, Jacques PF, Wolf PA, Magnani JW, Ellinor PT, Wang TJ, Levy D, Vasan RS, Benjamin EJ.

Circulation. 2010 Jan 19;121(2):200-7. doi: 10.1161/CIRCULATIONAHA.109.882241. Epub 2010 Jan 4.


Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004).

Koton S, Tanne D, Green MS, Bornstein NM.

Neuroepidemiology. 2010;34(2):90-6. doi: 10.1159/000264826. Epub 2009 Dec 11.


Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study.

Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MS.

Stroke. 2009 Aug;40(8):2805-11. doi: 10.1161/STROKEAHA.109.549576. Epub 2009 Jun 25.


Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.

Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC Jr, Wilson PW; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council.

Circulation. 2009 May 5;119(17):2408-16. doi: 10.1161/CIRCULATIONAHA.109.192278. Epub 2009 Apr 13. Erratum in: Circulation. 2009 Jun 30;119(25):e606. Hong, Yuling [added].


Blood markers for the prognosis of ischemic stroke: a systematic review.

Whiteley W, Chong WL, Sengupta A, Sandercock P.

Stroke. 2009 May;40(5):e380-9. doi: 10.1161/STROKEAHA.108.528752. Epub 2009 Mar 12. Review.


Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death.

Scirica BM, Cannon CP, Sabatine MS, Jarolim P, Sloane S, Rifai N, Braunwald E, Morrow DA; PROVE IT-TIMI 22 Investigators.

Clin Chem. 2009 Feb;55(2):265-73. doi: 10.1373/clinchem.2008.117192. Epub 2008 Dec 12.


Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).

Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Dávalos A, Erilä T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Köhrmann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G; Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy Investigators.

Stroke. 2008 Dec;39(12):3316-22. doi: 10.1161/STROKEAHA.107.510768. Epub 2008 Oct 16.


Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation.

Naya T, Yukiiri K, Hosomi N, Takahashi T, Ohkita H, Mukai M, Koziol JA, Kohno M.

Cerebrovasc Dis. 2008;26(4):434-40. doi: 10.1159/000155640. Epub 2008 Sep 18.


State of the art: using natriuretic peptide levels in clinical practice.

Maisel A, Mueller C, Adams K Jr, Anker SD, Aspromonte N, Cleland JG, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazaa A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhyden M, Yancy CW, Zannad F, Braunwald E.

Eur J Heart Fail. 2008 Sep;10(9):824-39. doi: 10.1016/j.ejheart.2008.07.014. Epub 2008 Aug 29. Review.


Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.

Montaner J, Perea-Gainza M, Delgado P, Ribó M, Chacón P, Rosell A, Quintana M, Palacios ME, Molina CA, Alvarez-Sabín J.

Stroke. 2008 Aug;39(8):2280-7. doi: 10.1161/STROKEAHA.107.505354. Epub 2008 Jun 5.

Supplemental Content

Support Center